E-ISSN 2146-9369 | ISSN 2146-3158
 

Research Article 


Evaluation of COVID-19 Patients with Chronic Kidney Disease

Yasaman Sadat Keshmiri, Sina Khosravi Mirzaei, Shahnaz Sali, Davood Yadegarynia, Sara Abolghasemi, Shabnam Tehrani, Amir Zamani, Mohamad Mehdi Derisi.


Cited By:2

Abstract
Objectives: The present study seeks to provide insight into managing patients with chronic kidney disease (CKD) infected with COVID-19.<br>Methods: Patients with COVID-19 with CKD were included in the study. The eligible patients were divided into four groups: 1) patients who were not on dialysis, 2) patients on maintenance dialysis, 3) patients who underwent dialysis following COVID-19, 4) patients with a history of a kidney transplant. After reviewing clinical charts, nursing records, laboratory findings, radiological reports, and other medical records of CKD patients with COVID-19 confirmed infection, clinical presentation, laboratory data, radiology findings, and results were extracted from documented medical records. The epidemiological, clinical, laboratory and outcome characteristics of the subgroups were evaluated and compared.<br>Results: Seventy-eight patients were included into the study. Hypertension (50 cases, 72.5%), diabetes (44 cases, 63.8%), and Cardiovascular disease (26 cases, 38.2%) were the most common risk factors in the studied patients. Among all participants, 40 (52.6%) patients died. The most common symptom was dyspnea (56.6%), followed by dry cough (38.7%). Comparison of blood, inflammatory, biochemical, and clinical indices among the patients ' groups show that LDH (P=0.022), AST (P=0.038), and ALT (P= 0.004) indices were significantly different between groups of patients. According to the results in Table 3, Unilateral ground-glass opacity (GGO) in the radiological findings of the Non-dialysis CKD group was significantly (P=0.50) higher than the other groups.<br>Conclusion: It can be concluded that CKD is one of the critical factors that can cause poor prognosis in COVID-19 patients. J Microbiol Infect Dis 2021; 11(3):152-158.

Key words: COVID19, chronic kidney disease, Dialysis, Transplant


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Yasaman Sadat Keshmiri
Articles by Sina Khosravi Mirzaei
Articles by Shahnaz Sali
Articles by Davood Yadegarynia
Articles by Sara Abolghasemi
Articles by Shabnam Tehrani
Articles by Amir Zamani
Articles by Mohamad Mehdi Derisi
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Yasaman Sadat Keshmiri, Sina Khosravi Mirzaei, Shahnaz Sali, Davood Yadegarynia, Sara Abolghasemi, Shabnam Tehrani, Amir Zamani, Mohamad Mehdi Derisi. Evaluation of COVID-19 Patients with Chronic Kidney Disease. J Microbiol Infect Dis. 2021; 11(3): 152-158 . doi:10.5799/jmid.993902


Web Style

Yasaman Sadat Keshmiri, Sina Khosravi Mirzaei, Shahnaz Sali, Davood Yadegarynia, Sara Abolghasemi, Shabnam Tehrani, Amir Zamani, Mohamad Mehdi Derisi. Evaluation of COVID-19 Patients with Chronic Kidney Disease. https://www.jmidonline.org/?mno=302657190 [Access: April 29, 2024]. doi:10.5799/jmid.993902


AMA (American Medical Association) Style

Yasaman Sadat Keshmiri, Sina Khosravi Mirzaei, Shahnaz Sali, Davood Yadegarynia, Sara Abolghasemi, Shabnam Tehrani, Amir Zamani, Mohamad Mehdi Derisi. Evaluation of COVID-19 Patients with Chronic Kidney Disease. J Microbiol Infect Dis. 2021; 11(3): 152-158 . doi:10.5799/jmid.993902



Vancouver/ICMJE Style

Yasaman Sadat Keshmiri, Sina Khosravi Mirzaei, Shahnaz Sali, Davood Yadegarynia, Sara Abolghasemi, Shabnam Tehrani, Amir Zamani, Mohamad Mehdi Derisi. Evaluation of COVID-19 Patients with Chronic Kidney Disease. J Microbiol Infect Dis. (2021), [cited April 29, 2024]; 11(3): 152-158 . doi:10.5799/jmid.993902



Harvard Style

Yasaman Sadat Keshmiri, Sina Khosravi Mirzaei, Shahnaz Sali, Davood Yadegarynia, Sara Abolghasemi, Shabnam Tehrani, Amir Zamani, Mohamad Mehdi Derisi (2021) Evaluation of COVID-19 Patients with Chronic Kidney Disease. J Microbiol Infect Dis, 11 (3), 152-158 . doi:10.5799/jmid.993902



Turabian Style

Yasaman Sadat Keshmiri, Sina Khosravi Mirzaei, Shahnaz Sali, Davood Yadegarynia, Sara Abolghasemi, Shabnam Tehrani, Amir Zamani, Mohamad Mehdi Derisi. 2021. Evaluation of COVID-19 Patients with Chronic Kidney Disease. Journal of Microbiology and Infectious Diseases, 11 (3), 152-158 . doi:10.5799/jmid.993902



Chicago Style

Yasaman Sadat Keshmiri, Sina Khosravi Mirzaei, Shahnaz Sali, Davood Yadegarynia, Sara Abolghasemi, Shabnam Tehrani, Amir Zamani, Mohamad Mehdi Derisi. "Evaluation of COVID-19 Patients with Chronic Kidney Disease." Journal of Microbiology and Infectious Diseases 11 (2021), 152-158 . doi:10.5799/jmid.993902



MLA (The Modern Language Association) Style

Yasaman Sadat Keshmiri, Sina Khosravi Mirzaei, Shahnaz Sali, Davood Yadegarynia, Sara Abolghasemi, Shabnam Tehrani, Amir Zamani, Mohamad Mehdi Derisi. "Evaluation of COVID-19 Patients with Chronic Kidney Disease." Journal of Microbiology and Infectious Diseases 11.3 (2021), 152-158 . Print. doi:10.5799/jmid.993902



APA (American Psychological Association) Style

Yasaman Sadat Keshmiri, Sina Khosravi Mirzaei, Shahnaz Sali, Davood Yadegarynia, Sara Abolghasemi, Shabnam Tehrani, Amir Zamani, Mohamad Mehdi Derisi (2021) Evaluation of COVID-19 Patients with Chronic Kidney Disease. Journal of Microbiology and Infectious Diseases, 11 (3), 152-158 . doi:10.5799/jmid.993902